Absence of specific cutaneous manifestations of severe acute respiratory syndrome coronavirus 2 in a reference center in Brazil

Prevalence and characteristics of dermatological manifestations in COVID‐19 positive dermatologists: Report from a web‐based survey in India

“…8,9 While studies from Brazil and India have found vasculitic lesions to be uncommon. [4][5][6] In a previous Indian study, none of the asymptomatic, mild or moderate cases developed vasculitic lesions. 10 Another interesting point is that despite a huge number of COVID-19 cases in India, reports describing mucocutaneous manifestations are scarce.…”

“…Indeed, studies that describe changes in patients with skin of colour (SOC) are limited and the available literature suggests that vasculitic lesions are uncommon in this population. [4][5][6] We conducted a web-based survey among Indian dermatologists who were confirmed cases of COVID-19. The idea behind this purposive sampling technique was the expectation that dermatologists can provide unique information as they would be unlikely to miss mucocutaneous signs and symptoms in themselves.…”

How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World

“…In Brazil, there was no evidence of specific cutaneous manifestations in critical patients that could definitively be attributed to SARS-CoV-2 infection. 82 Since then, a minority of mild cases demonstrating exanthema, urticaria, pruritus sine materia, vasculitis, and telogen effluvium have been observed and could arguably be related to COVID-19. 3 …”

The underrepresentation of “COVID toes” in skin of color: An example of racial bias or evidence of a tenuous disease association?

“… 4 Pangti et al 5 similarly reported that cutaneous manifestations were uncommon in pigmented skin in a series of 138 patients with confirmed COVID-19 diagnoses. Given that the study by Pangti et al 5 was performed in India by Indian dermatologists and the one by Avancini et al 1 in Brazil by Brazilian dermatologists, it is likely they did not have inadequate training in skin of color.…”

“…To the Editor: We read with interest the article by Avancini et al 1 describing the absence of cutaneous manifestations associated with coronavirus disease 2019 (COVID-19) in a large, dedicated severe acute respiratory syndrome coronavirus 2 hospital in Brazil. Of the 3982 patients hospitalized with COVID, dermatology was consulted for 98, with no “COVID toes” identified among them.…”